Entyce

Verify with FDA CVM →

138 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
138
Total Reports
64
Deaths Reported
4640.0%
Death Rate

Active Ingredients

Entyce

Administration Routes

OralUnknown

Species Affected

Dog 136
Cat 2

Most Affected Breeds

Retriever - Labrador 14
Shih Tzu 12
Retriever - Golden 10
Terrier - Yorkshire 9
Chihuahua 7
Terrier (unspecified) 6
Spitz - German Pomeranian 6
Dog (unknown) 5
Bulldog - French 4
Crossbred Canine/dog 4

Most Reported Reactions

Death by euthanasia 53
Lethargy (see also Central nervous system depression in Neurological) 48
Vomiting 40
Not eating 36
Diarrhoea 30
Anorexia 23
Decreased appetite 23
Elevated serum alkaline phosphatase (ALP) 21
Weight loss 20
Seizure NOS 19
Elevated alanine aminotransferase (ALT) 19
Leucocytosis NOS 16

Outcome Breakdown

Ongoing
59 (42.8%)
Euthanized
53 (38.4%)
Died
11 (8.0%)
Outcome Unknown
8 (5.8%)
Recovered/Normal
7 (5.1%)

Data Summary

Metric Value
Total adverse event reports 138
Reports involving death 64
Case-fatality rate (reported events) 4640.0%
Distinct species in reports 2
Distinct breeds in reports 20
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Entyce Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 138 adverse event reports referencing Entyce, including 64 reports in which the animal died — a 4640.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Entyce. Reported administration routes include Oral, Unknown. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Entyce reports are Dog (136 reports), Cat (2 reports), with Dog accounting for the largest share. Within those species, Retriever - Labrador (14), Shih Tzu (12), Retriever - Golden (10) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Entyce are Death by euthanasia (53), Lethargy (see also Central nervous system depression in Neurological) (48), Vomiting (40), Not eating (36). Of the 138 reports with a coded outcome, Ongoing is the leading category at 42.8%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Entyce.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial